OPCML Fragment-based Environmental Monitoring and Diagnostic Systems

Publication ID: 24-11857624_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “OPCML Fragment-based Environmental Monitoring and Diagnostic Systems,” Published Technical Disclosure No. 24-11857624_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857624_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,624.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of OPCML fragments to develop novel systems and methods for monitoring water quality, detecting agricultural pests, diagnosing neurological disorders, monitoring food spoilage, and detecting environmental toxins.

Background and Problem Solved

The original patent disclosed the use of OPCML fragments in cancer therapy, but it did not explore their potential in other fields. This inventive concept addresses the need for innovative solutions in environmental monitoring and diagnostics, where traditional methods are often inadequate or ineffective.

Detailed Description of the Inventive Concept

The newly generated claims describe various systems and methods that utilize OPCML fragments as biomarkers or sensors to detect specific environmental pollutants, pests, neurological disorders, food spoilage, or toxins. For instance, claim 1 describes a system for monitoring water quality by detecting OPCML fragments indicative of pollution. Claim 2 outlines a method for detecting agricultural pests using OPCML fragments as biomarkers. Similarly, claims 3-5 describe devices and systems for diagnosing neurological disorders, monitoring food spoilage, and detecting environmental toxins.

Novelty and Inventive Step

The new claims introduce a fundamentally new application of OPCML fragments, transitioning from cancer therapy to environmental monitoring and diagnostics. This shift in focus and technology constitutes a significant inventive step, as it requires a deep understanding of the OPCML fragment's properties and their potential uses in diverse fields.

Alternative Embodiments and Variations

Other potential implementations of the inventive concept could include using OPCML fragments in wearable devices for personal health monitoring, developing point-of-care diagnostic tools for remote or resource-constrained areas, or integrating OPCML fragments with machine learning algorithms for enhanced predictive capabilities.

Potential Commercial Applications and Market

The OPCML fragment-based environmental monitoring and diagnostic systems have vast commercial potential, targeting industries such as environmental consulting, agricultural technology, healthcare, and food safety. The market for these systems is substantial, driven by growing concerns about environmental sustainability, public health, and food security.

CPC Classifications

SectionClassGroup
A A61 A61K39/39558
A A61 A61K31/404
A A61 A61K31/506
A A61 A61K31/517
A A61 A61K31/555
A A61 A61K31/7064
A A61 A61K38/1774
A A61 A61K45/06
C C07 C07K16/28
C C07 C07K16/2863
C C07 C07K16/32
C C12 C12Q1/6886
C C12 C12Q2600/118
C C12 C12Q2600/156
C C12 C12Q2600/158

Original Patent Information

Patent NumberUS 11,857,624
TitleCancer therapeutic methods utilizing OPCML fragment
Assignee(s)PAPYRUS THERAPEUTICS, INC.